人类TET2突变的克隆血液形成扩张是由干细胞与髓状后代之间的明显炎症信号反应驱动的
Hector Huerga Encabo1, Giuseppe D'Agostino2, Katherine Sturgess1
1The Francis Crick Institute, London, London, United Kingdom.
Blood cancer discovery
|December 4, 2025
概括
由TET2突变驱动的克隆造血 (CH) 不同地影响干细胞及其后代. TET2突变干细胞对炎症的适应性降低,而它们的髓状细胞会加剧炎症,促进CH扩张.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 克隆性血液形成 (CH) 的患病率随着年龄的增长而增加.
- 冠状病毒与感染和癌症的不良结果有关.
- 了解CH与免疫系统的相互作用对于治疗的发展至关重要.
研究的目的:
- 为了研究CH中TET2突变的细胞特异性影响.
- 阐明TET2突变对造血干细胞和原生细胞 (HSPC) 以及其髓状后代的影响.
- 了解炎症环境中的CH-免疫系统反应.
主要方法:
- 使用了人类细胞模型.
- 进行了多原子分析.
- 在造血干细胞和前代细胞 (HSPCs) 和髓状后代中研究了TET2突变.
主要成果:
- TET2突变对冲影响HSPC和髓状后代.
- 在TET2突变的HSPC中,表现出AP-1转录因子的表观遗传沉默.
- 在TET2突变的HSPC中,对系统性炎症的反应减弱.
- 来自TET2突变HSPCs的髓状细胞有助于恶化的炎症.
- TET2突变CH促进HSPC的干性和通过髓状后代的炎症.
结论:
- TET2突变产生双重效应:增加HSPC的干性和通过髓状细胞增加炎症.
- 这些发现为在炎症应激下TET2-CH扩张提供了机理性的见解.
- 这项研究协调了CH如何促进干和炎症.
更多相关视频
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Hematopoiesis
8.5K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.5K
Production of Formed Elements
3.6K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
3.6K
Lineage Commitment
4.0K
Commitment is the process whereby stem cells:
4.0K
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K


